Bharat Serums Gets CDSCO Panel Nod for Phase III Trial of IVIG in Chronic ITP Dr. Divya Colin26 Jun 2025 7:57 PM ISTNew Delhi: Bharat Serums and Vaccines has received approval from the Subject Expert Committee (SEC) functional under the Central Drugs Standard...
SEC Clears Hemopurifier Device for Cancer Study in Indian Patients Parthika Patel26 Jun 2025 7:50 PM ISTNew Delhi: In a step toward advancing medical device-based cancer care, the Subject Expert Committee (SEC) under the Oncology division of the Central...
Label Update for AstraZeneca's Olaparib Cleared by CDSCO Panel Parthika Patel25 Jun 2025 5:11 PM ISTNew Delhi: In a recent regulatory update, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard Control...
Biocon Gets CDSCO Panel Nod to Market Trastuzumab PGS in India Dr. Divya Colin25 Jun 2025 4:51 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Oncology and Hematology, functioning under the Central Drugs Standard Control Organisation (CDSCO),...
Laurus Labs Asked to Submit Justification, Data for Pediatric Darunavir-Ritonavir FDC Proposal Farhat Nasim23 Jun 2025 3:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Antimicrobial & Antiviral under the Central Drugs Standard Control Organisation (CDSCO) has asked...
State Drug Alert: CDSCO Flags 128 Batches Including Paracetamol, Dapagliflozin Farhat Nasim22 Jun 2025 3:00 PM ISTNew Delhi: As part of its ongoing quality surveillance efforts, the Central Drugs Standard Control Organisation (CDSCO) has flagged more than 120...
SEC Recommends Market Authorization for Elobixibat 5 mg Tablets by Exemed Pharma Parthika Patel22 Jun 2025 10:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Gastroenterology and Hepatology division of the Central Drugs Standard Control Organization...
AstraZeneca's Oral PCSK9 Inhibitor AZD0780 Cleared for Phase III Trial by CDSCO Panel Dr. Divya Colin22 Jun 2025 9:30 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to AstraZeneca Pharma...
58 Drug Batches, Including Dexona Fail CDSCO Quality Standards Farhat Nasim21 Jun 2025 8:08 PM ISTNew Delhi: In its continued effort to ensure drug safety and compliance, the Central Drugs Standard Control Organisation (CDSCO) has flagged 58...
Sun Pharma Gets Relief on Packaging Norms for Pantoprazole-Levosulpiride FDC Parthika Patel21 Jun 2025 4:18 PM ISTNew Delhi: In a regulatory relief to the company, the Subject Expert Committee (SEC) under the Gastroenterology and Hepatology division of the Central...
Mankind Pharma Gets CDSCO Panel Nod to Conduct Phase III Trial of Resmetirom Tablets Parthika Patel21 Jun 2025 11:45 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Gastroenterology and Hepatology division of the Central Drugs Standard Control Organisation...
Zydus Gets CDSCO Panel Nod to Conduct Phase IV Trial for Indacaterol-Budesonide FDC Inhalation Dr. Divya Colin20 Jun 2025 11:45 PM ISTNew Delhi: In response to the proposal presented by Zydus Healthcare, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
